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Abstract We have investigated the response of normal and
cancer cells to exposure a combination of celecoxib (Celbx)
and 5-fluorouracil (5-FU) using a lab-on-a-chip microfluidic
device. Specifically, we have tested the cytotoxic effect of
Celbx on normal mouse embryo cells (Balb/c 3T3) and
human lung carcinoma cells (A549). The single drugs or
their combinations were adjusted to five different concen-
trations using a concentration gradient generator (CGG) in a
single step. The results suggest that Celbx can enhanced the
anticancer activity of 5-FU by stronger inhibition of cancer
cell growth. We also show that the A549 cancer cells are
more sensitive to Celbx than the Balb/c 3T3 normal cells.
The results obtained with the microfluidic system were
compared to those obtained with a macroscale in vitro cell
culture method. In our opinion, the microfluidic system
represents a unique approach for an evaluation of cellular
response to multidrug exposure that also is more simple than
respective microwell plate assays.
Keywords Chemotherapy resistance . Multidrug tests .
Microfluidic gradient system . Lab-on-a-chip . Celecoxib .
5-fluorouracil
Introduction
Cancer therapies have changed dramatically during the past
century. Even if surgery or radiotherapy are still used as the
primary treatments of many types of cancer, chemotherapy
plays also an important role to prevent its recurrence [1, 2].
In fact, chemotherapeutic drugs are most effective when
given in combination (combined chemotherapy). In the
combined chemotherapy drugs with different mechanisms
of action are used, decreasing the possibility that resistant
cancer cells will grow up. When drugs with different effects
are combined, each drug can be used at its optimal dose,
without intolerable side effects [3]. New anticancer agents
are also being tested as well as new combinations tried.
Unfortunately, in many cases an objective response rate for
treatment is still not satisfactory. There are multiple reasons
for chemotherapy failure in patients’ treatment, involving a
variety of anatomic, pharmacological and biochemical
mechanisms. Therefore, instead of unification of cancer
treatment for all patients the future is in the personalization
of cancer therapy. This generates the needs for adequate
assay scheme to efficiently screen new potential drug can-
didates or/and new drug combinations.
Nowadays, numerous studies demonstrate that the anti-
cancer activity of standard chemotherapeutic agents can be
enhanced by using inhibitors of cyclooxygenase-2 (COX-2)
enzyme [4]. Nonsteroidal anti-inflammatory drugs (NSAIDs)
i.e. celecoxib (Celbx) in combination with cytostatic drug can
improve their antitumor effects [5].
In order to better predict the clinical response to drugs’
combination, a cell culture model that mimic in vivo behav-
iour is required [6]. For these purposes, the use of a
microfluidic-based cell-culture platform seems to be a prom-
ising alternative to the conventional cell culture methods [7,
8]. The construction of small-scale devices permits also for
Electronic supplementary material The online version of this article
(doi:10.1007/s00604-013-1009-4) contains supplementary material,
which is available to authorized users.
E. Jastrzebska (*) :A. Rakowska :M. Chudy :A. Dybko :
Z. Brzozka
Department of Microbioanalytics, Institute of Biotechnology,
Warsaw University of Technology, 00-664 Warsaw, Poland
e-mail: ejastrzebska@ch.pw.edu.pl
S. Flis : Z. Jastrzebski
Department of Pharmacology, National Medicines Institute,
00-725 Warsaw, Poland
Microchim Acta (2013) 180:895–901
DOI 10.1007/s00604-013-1009-4
using of low cell numbers. It can be important especially
during anticancer drug screening of cancer cells isolated
from patient. Moreover, development of lab-on-a-chip sys-
tems provides novel methods of mimicking the complexity
of in vivo conditions through construction of properly de-
fined microchannels geometry. It enables to create high
value of the surface-to-volume-ratio (SAV). High value of
SAV in live organisms was also observed, therefore suitable
designing of this parameter in microchips is important.
Besides, lab-on-a-chip devices allow for more accurate
modelling of physical situations for both fundamental re-
search and drug development. In specially designed
microdevices, the control of essential signals in cellular
microenvironments is more precise than in a macroscale
[9, 10]. The cells in organisms are exposed to the microen-
vironmental signals (i.e. soluble factors, cell-cell interac-
tions, cell-extracellular matrix (ECM), physical forces),
which result in activation of cells behaviour. Cellular re-
sponses (i.e. self-renewal, differentiation, biosynthesis, me-
tabolism, apoptosis, migration or quiescence) are observed
in live tissues [9]. Usually, examination of these
bioprocesses in macroscale (on the 96-well plates) is diffi-
cult. However, numerous publications described microtools
for simultaneous and accurate controlling of various factors
such as: cells differentiation, migration and apoptosis
[11–13].
Microsystems are used for high-throughput screening
after cells exposition with a few signals, including chemical,
biochemical, physical and mechanical factors [9, 11–13].
Automatic concentration gradient generators as well as
controlled-diffusive mixing play an essential role especially
during the cytotoxicity assays [14]. First of all, it allows for
real-time monitoring of multifunction conditions/factors in a
single plate. Numerous protocols of the toxic effect analysis
have been established in miniaturized platforms/systems
integrated with a mixing gradient [12, 15–18]. Irimia et al.
described the microdevice developed in PDMS, which
contained two completely separated chemical gradients.
They were connected through a system of valves to one
main channel and two waste channels. The advantage of this
type of gradient was a possibility to manipulate a flow,
which could be directed either to the main channel or to
the waste channel [16]. Evaluation of many independent
conditions on various long-term cultures was performed
for example by Gomez et al. [19] and Prokop et al. [20].
Cells chemotactic responses, after exposing to different
chemokins, were evaluated on neutrophils, breast cancer
cells, human neural stem cells or lung carcinoma cells
[21–26]. In turn, Hosokawa et al. [27] presented a
microfluidic device with chemical gradient for a single-cell
cytotoxicity assay. The geometry of this microsystem con-
sists also a microcavity array for entrapment of single cells.
In special cavities (chambers) the single Hela cells were
trapped and treated with six different concentrations of
model compound—potassium cyanine (KCN). Results,
presented in this paper, indicated that the microsystem could
be used for detection of the concentration- and time-
dependent cytotoxicity at the single-cell level.
This work presents data of applying microfluidic cell
culture system containing concentration gradient generator
(CGG) as a platform for evaluation of drugs’ combinations.
The type of concentration gradient allows generating five
different concentrations of two chemotherapeutic agents.
We established the cytotoxic effect of Celbx and 5-FU on
normal mouse embryo cells (Balb/c 3T3) and human lung
carcinoma cells (A549). For this purpose we used an inte-
grated microfluidic gradient system, which can be used as
an alternative tool for rapid multidrug exposure examination
[28]. Moreover, response of both tested cell lines treated
with the combination of Celbx and 5-FU was examined.




The A549 (human lung carcinoma cell line) and Balb/c 3T3
(normal mouse embryo cell line) obtained from the ATCC
collection (Manassas, VA, USA, www.lgcstandards-
atcc.org) were used for cytotoxicity assays in both micro-
and macroscale experiments. Both macro- and microscale
cell cultures were carried out using the same media and
regime of medium exchange [28]. A549 cells were chosen
because lung cancer is one of the most common cancers in
the world as well as leading cause of cancer death in men
and women. Therefore, it gets an important social problem.
In turn, Balb/c 3T3 cell line, was chosen because the Euro-
pean Centre of Validation of Alternative Methods (ECVAM)
considered this in vitro model system for evaluating the
cytotoxicity and morphological transformation of chemicals
and metal compounds [29]. Moreover, Balb/c 3T3 cells
represent normal tissue, what seems to be a good model
for analysis of anticancer activity of the chosen drugs.
Assays in a microsystem
The reusable, hybrid (PDMS/glass) microsystem was used
during the studies (Fig. 1). Design and method of fabrication
of the microfluidic cell culture system for cytotoxicity tests
was presented in details in our previous work [30]. The
inhibitory effect of combination of two drugs (Celbx and
5-FU) was analyzed on the cells introduced and cultured in
the microsystem (see ESM). However, before these studies
the cytotoxic effect of single drugwas investigated. Therefore,
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both the A549 and Balb/c 3T3 cells response on five various
concentration of Celbx (range of 0÷120 μM) and 5-FU (range
of 0÷300 μM) was established in separate tests. After mixing
in CGG, in consecutive rows of culture microchambers, five
different concentrations of single drug was obtained. After
evaluation of the cytotoxic effect of single treatment,
multidrug tests in the microsystem were performed. In this
purpose, two different solutions of Celbx (120 μM) and 5-FU
(300 μM) into the microsystems were pumped. Drugs were
introduced through the CGG inlets with a flow rate of
1.2 μL min−1 for 50 min. The microdevices with the intro-
duced drugs (in both single and multidrug treatment) were
placed in the incubator for the next 24 or 48 h. For each tested
drug, the separate microsystem with proper cell line was used.
Finally, cell viability assay was performed using fluorescent
dyes (see ESM).
Assays in a macrosystem
Both cell lines (at a density of 1×104 cells per well)
were placed into flat bottom 96-well plates and allowed
to attach overnight. Growth inhibitory effects of Celbx
and 5-FU were evaluated by the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
(www.invitrogen.com), which measures mitochondrial activity
of viable cells. The cells were simultaneously treated with Celbx
and 5-FU or with each drug separately for 24 and 48 h. After the
treatment procedure, the medium was removed and cells were
incubated for 4 h at 37 °C in 50 μL per well with MTT solution
(final concentration 0.5 mg mL−1). Formazan crystals were
dissolved in 150 μL of 10 % SDS solution per well and the
absorbance was measured at 540 nm using a spectrophotometric
microplate reader Power Wave XS (Bio-Tek, Winooski, VT,
USA).
Statistical analysis
Experimental data are expressed as mean ± standard devia-
tion (SD) from at least four independent experiments. Data
were analysed using SigmaPlot version 11 software. Statis-
tical analysis was performed using the one-way ANOVA.




Good coherence between the theoretical and experimental
data during a flow of solution through the microdevice,
particularly in the CGG has been proved [28]. Results on
microsystem operations are given in ESM. The geometry of
the fabricated microsystem achieved uniform distribution of
cells in microchambers. Analysis within 24 h (using a mi-
croscope) of introduced A549 and Balb/c 3T3 cells showed
good morphology, comparable to control experiments in
which cells were cultured in 96-well plates. Figure 1b shows
A549 and Balb/c 3T3 cells cultured in the microchambers of
the microsystem for 24 h. Good adhesion to the glass
surface was observed. Two cell lines selected for the inves-
tigation represent normal and cancer tissue, what seems to
be a good model for analysis of anticancer activity of the
chosen drugs, i.e. Celbx and 5-FU. The microsystem
Fig. 1 a The microfluidic
system integrated with
concentration gradient
generator (CGG) consists of
PDMS and glass. b
Microchambers with Balb/c
3T3 and A549 cells cultured for
24 h
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enabled to analyse of cell morphology and cytotoxicity
simultaneously.
Both cultured cell lines were exposured to combination
of Celbx with 5-FU. Additionaly, for the comparision the
cytotoxic effect of single drug was also evaluated. In our
previous work, we described results for incubation of A549
cells with 5-FU [28]. Here, we investigated the cytotoxic
effect of Celbx on A549 and Balb/c 3T3 cells as well as 5-
FU on Balb/c 3T3 cells (see ESM). Moreover, the cytotoxic
effect on the cells after multidrug exposure was investigated.
Both cell lines were simultaneously exposed to Celbx (0–
120 μM) and 5-FU (0–300 μM) in the microfluidic device
(microsystem). Cells were exposed to different concentra-
tion for 24 and 48 h. Figure 2 shows that Celbx and 5-FU,
separately dosed, exert time-dependent cytotoxic effect on
carcinoma A549 cells. The strongest cytotoxic effect of
single drug was determined for concentrations from 60 to
120 μM for Celbx and from 150 to 300 μM for 5-FU.
Incubation of the cells with combination of tested drugs
enhanced the cytotoxic effect in comparison to drugs intro-
duced separetly. For each period of time (24 and 48 h)
viability decrease of A549 cells’ after incubtion with com-
bination of Celbx and 5-FU was observed. The ranges of
drugs’ concentrations, in which enhanced cytotoxic effect is
the strongest can be determined (Fig. 2). Decrease of A549
cells’ viability was observed in ranges of Celbx (39÷
83 μM) and 5-FU (202÷93 μM) for 24 h and Celbx (19÷
117 μM) and 5-FU (253÷8 μM) for 48 h. The lowest A549
cells’ viability (30 %) after 48 h incubation with combina-
tion of 60 μM Celbx and 150 μM 5-FU in comparison to
single drugs administration (50 %) was determined.
Similar experiments were performed on Balb/c 3T3 cells.
Figure 3 shows that both agents as well as their combina-
tions were less effective on Balb/c 3T3 cells. Exposure to
Celbx (without 5-FU), which seems to be the most potent
agent, decrease to 65 % Balb/c 3T3 cell viability at the
highest concentration tested after 24 and 48 h of incubation.
Whereas, in the same conditions (120 μM of Celbx), the
viability of the A549 cells decreased to 20 %. The results
obtained in this study suggest that Celbx can enhance anti-
cancer activity of 5-FU by stronger inhibition of cancer cell
growth as well as indicate its own anticancer activity. How-
ever, we observed that application of both drugs enhanced
also the cytotoxic effect of the Balb/c 3T3 cells. Balb/c 3T3
cell viability decreased after incubation with all drugs’
combination.
Comparison the toxic effect of the tested drugs
between micro and macroscale
The results obtained with the microfluidic device were com-
pared with those obtained using conventional in vitro cell
Fig. 2 Effects of celecoxib
(Celbx), 5-fluorouracil (5-FU)
or their combination on
viability of A549 in
microfluidic system and 96-
well plates after 24 and 48 h.
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culture method (macrosystem) in a 96-well plate at
selected concentrations (Figs. 2 and 3). The presented
results show that cell treatment in the microfluidic de-
vice lead to a smaller decrease of viability of A549
cells than in 96-well plates. The enhanced cytotoxic
effect for both cell lines in micro- and macroscale was
observed. The highest discrepancy between both scales
for A549 cells 24 h incubated with drugs’ combination
was established. Our results obtained for single drug
treatment in both cultivation types (microsystem and
96-well plate) are more comparable than those obtained
for drug combination treatment. Regression analysis in-
dicates significant correlation of Celbx and 5-FU cyto-
toxicity between two evaluated systems, because high
Pearson’s correlation coefficients (R2) were calculated.
For single treatments, in most cases, we obtained posi-
tive correlation coefficient parameters with P values
below 0.05 (Table 1).
Moreover, 5-FU at the highest tested concentration is
stronger in the microsystem than in the 96-well plate. Ad-
ditionally, Balb/c 3T3 cells were more sensitive to drug
combinations in the microsystem (Fig. 3).
Several factors could have influence on these discrep-
ancies in drug efficiency between the evaluated systems.
Most likely, the discrepancy between the two evaluated
systems could result from the differences in the cell
culture conditions and different access of the anticancer
drug to the cells cultivated in the macroscale. First of
all, in the 96-well plates, cells were cultured in static
conditions, while in the microsystem culture media were
periodically replaced and cell cultures were rinsed with
drugs and solution of CAM and PI. However, the flow
of reagents that occurs in our microdevice, can mimic
in vivo condition during the provision of drugs and
substances into the living body. On the other hand, the
cells division in microscale (where SAV is high [10])
Fig. 3 Effects of celecoxib
(Celbx), 5-fluorouracil (5-FU)
or their combination on
viability of Balb/c 3T3 cells in
microfluidic system and 96-
well plates after 24 and 48 h.




Table 1 The Pearson correlation values (R) between microfluidic
device (microsystem) and well plate culture (macrosystem) calculated
for single treatments
Drug A549 cells Balb/c 3T3 cells
Microsystem/Macrosystem
Celbx 0.894a 0.903a 24 h
5-FU 0.970a 0.768b
Celbx 0.999a 0.805b 48 h
5-FU 0.925a 0.825b
a The pair of variables with positive correlation coefficients and P value
below 0.05 tends to increase together
b For pairs with P values greater than 0.05, there is no significant
relationship between the two variables
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can result from differences in the cells response on the
drugs exposure.
Another hypothesis concerning the obtained discrepancy
could result from absorption in PDMS of the tested cytotoxic
drugs. Therefore, we investigated absorption of drugs,
according to previously elaborated procedure utilizing gas
chromatography [28, 30]. We proved that after several tests
performed in the same microsystem, the PDMS block did not
absorb the 5-FU (data shown in previous publication) as well
as Celbx. In the chromatogram of standard solution of Celbx,
there were peaks corresponding to Celbx (retention time
16.47 min) and DMSO (retention time 1.33 min). We inves-
tigated that the tested PDMS pieces (obtained from the
microsystem) contains only DMSO solution (retention time
1.33 min). We proved that in this case differences between
micro and macro scale can not result from absorption in
PDMS of the tested cytotoxic drugs. However, the usage of
other drugs requires examination of their absorption in PDMS.
Conclusions
This study demonstrated response of human lung carcinoma
cells (A549) and normal mouse embryo cells (Balb/c 3T3)
cells on the exposure of combination celecoxib (Celbx) with
5-fluorouracil (5-FU). The application of the CGG in the
microsystem improved repeatable generation of different
drugs concentration. Moreover, during the multidrug studies
different mixtures of the tested drugs (Celbx and 5-FU) were
obtained automatically and simultaneously. It allows avoiding
operator’s errors, which can occur during the preparation of
the solutions and it enables to obtain reproducible results. The
calculated correlations and high values of Pearson parameter
between micro- and macroscale have proved that the
microsystem can be an alternative tool for performing the
multidrug cytotoxicity assays. The results suggest that Celbx,
nonsteroidal anti-inflammatory drug (NSAID), inhibits the
growth of cancer cells and indicates anticancer properties.
We proved that after cells incubation with Celbx the viability
of A549 cells was lower than Balb/c 3T3 normal cells. More-
over, Celbx in combination with 5-FU enhances the antitumor
activity. The results confirmed that Celbx inhibits the growth
of cancer cells as well as indicates its anticancer properties.
The results obtained in the microfluidic system were also
compared with classical tests (macroscale). Our results indi-
cate that the microfluidic device can be used for testing the
cytotoxic effect of drugs’ combination. It is important to note
that despite of differences between both evaluated systems,
the microfluidic device shows the possibility to test the cyto-
toxic effect of both drugs: Celbx and 5-FU. This comparison
(micro with macroscale) proved possibility to perform
multidrug tests in microscale. Our results suggest that the fabri-
cated microfluidic system (containing CGG) can be a unique
approach for first evaluation of the cellular responses. It gives
possibility for development of simplified methods for simulta-
neous testing of anticancer drugs or other new synthesized
compounds, which are potentially biological active. We believe
that our investigations improve validation and standardization
of microsystem for cytotoxicity assays.
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